Rupinder Kaur
Impact in
- Infectious Diseases top 1%
- Antifungal resistance and susceptibility
- Epidemiology top 5%
- Fungal Infections and Studies
- Pneumocystis jirovecii pneumonia detection and treatment
Papers in
-
- Antifungal resistance and susceptibility 38
- Epidemiology 30
- Fungal Infections and Studies 25
- Pneumocystis jirovecii pneumonia detection and treatment 9
- Co-authors
- Brendan P. Cormack (4 shared papers)Biao Ma (1 shared paper)Anand Bachhawat (6 shared papers)Margaret L. Zupancic (1 shared paper)Irene Castaño (2 shared papers)Zorawar Singh (1 shared paper)Sriram Balusu (3 shared papers)Sapan Borah (4 shared papers)
- Journals
- Journal of Biological Chemistry (6 papers)Antimicrobial Agents and Chemotherapy (4 papers)Biochemical Journal (4 papers)Nucleic Acids Research (3 papers)PLoS Pathogens (2 papers)
- Partner nations
- IndiaUnited StatesSaudi Arabia
In The Last Decade
Rupinder Kaur
72 papers receiving 2.0k citations
Peers
Comparison fields: 5 of 117
- Infectious Diseases 1.1k
- Epidemiology 728
- Molecular Biology 808
- Oncology 277
- Microbiology 63
Countries citing papers authored by Rupinder Kaur
This map shows the geographic impact of Rupinder Kaur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rupinder Kaur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rupinder Kaur more than expected).
Fields of papers citing papers by Rupinder Kaur
This network shows the impact of papers produced by Rupinder Kaur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rupinder Kaur. The network helps show where Rupinder Kaur may publish in the future.
Co-authors
The 25 scholars most cited alongside Rupinder Kaur, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 75 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 228 | |
| 2 | 2005 | 215 | |
| 3 | 2004 | 136 | |
| 4 | Use of Malondialdehyde as a Biomarker for Assessing Oxidative Stress in Different Disease Pathologies: a Review | 2014 | 103 |
| 5 | 2012 | 88 | |
| 6 | 2019 | 81 | |
| 7 | 1999 | 72 | |
| 8 | 2003 | 67 | |
| 9 | 2014 | 57 | |
| 10 | 2003 | 52 | |
| 11 | 2014 | 50 | |
| 12 | 2020 | 47 | |
| 13 | 2010 | 43 | |
| 14 | 2018 | 41 | |
| 15 | 2010 | 40 | |
| 16 | 2011 | 39 | |
| 17 | 2018 | 39 | |
| 18 | 2001 | 38 | |
| 19 | 2012 | 37 | |
| 20 | 2013 | 35 |
About Rupinder Kaur
Rupinder Kaur is a scholar working on Infectious Diseases, Epidemiology, Molecular Biology, Oncology and Cell Biology, having authored 75 papers that have together received 2.0k indexed citations. Recurring topics across this work include Antifungal resistance and susceptibility (38 papers), Fungal Infections and Studies (25 papers), Fungal and yeast genetics research (14 papers), Peptidase Inhibition and Analysis (12 papers), Pneumocystis jirovecii pneumonia detection and treatment (9 papers), Drug Solubulity and Delivery Systems (3 papers), Fungal Biology and Applications (3 papers) and Diabetes Management and Research (3 papers). The work is most often cited by research in Infectious Diseases (1.1k citations), Epidemiology (728 citations), Molecular Biology (808 citations), Oncology (277 citations) and Microbiology (63 citations). Rupinder Kaur has collaborated with scholars based in India, United States and Saudi Arabia. Frequent co-authors include Brendan P. Cormack, Biao Ma, Anand Bachhawat, Margaret L. Zupancic, Irene Castaño, Zorawar Singh, Sriram Balusu, Sapan Borah, Raju Shivarathri and Imran Kazmi. Their work appears in journals such as Journal of Biological Chemistry, Antimicrobial Agents and Chemotherapy, Biochemical Journal, Nucleic Acids Research and PLoS Pathogens.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.